Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4821700 | 0.91 | ALDH1A1 (0.38) | ALDH1A1ACHE | |
| SCHEMBL439564 | 0.91 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL14733083 | 0.82 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL7926774 | 0.81 | ALDH1A1 (0.34) | ALDH1A1ACHE | |
| SCHEMBL15641737 | 0.80 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL29620670 | 0.80 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9030388 | 0.79 | — | — | |
| SCHEMBL14065529 | 0.77 | — | — | |
| SCHEMBL15440835 | 0.77 | MEN1 (0.35) | ALDH1A1 | |
| SCHEMBL15494048 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8664247-B2 | Acyclic organonitro compounds for use in treating cancer | RADIORX, INC. (US) | 2014-03-04 | — | — | US | disclosed |
| US-20130053418-A1 | ACYCLIC ORGANONITRO COMPOUNDS FOR USE IN TREATING CANCER | NORTHROP GRUMMAN SYSTEMS CORPORATION | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053418-A1 | ACYCLIC ORGANONITRO COMPOUNDS FOR USE IN TREATING CANCER | GMNN, OTC, OAT | ALDH1A1 1345/4885ACHE 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.